Dow Jones 30 Stocks SEC Filings — March 10, 2026

10-03-2026

Lifevantage Corporation (LFVN) filed a Form S-3 shelf registration statement on March 10, 2026, to offer and sell up to $75M in aggregate of common stock, preferred stock, debt securities, warrants, or units from time to time on terms to be determined. As of March 4, 2026, the company had 12,804,772 shares of common stock outstanding at a last reported sale price of $4.91 per share, with the aggregate market value of non-affiliate shares at $65.6M based on data as of February 26, 2026. No securities were sold under General Instruction I.B.6 of Form S-3 in the prior 12 months, and proceeds would be used for general corporate purposes including working capital and potential acquisitions, though none are currently planned.

• ·Authorized capital stock: 40M shares of common stock ($0.0001 par value) and 5M shares of preferred stock ($0.0001 par value).
• ·Common stock listed on Nasdaq Capital Market under symbol 'LFVN'.
• ·Shelf limited to no more than one-third of non-affiliate market value ($75M threshold) in any 12-month period until aggregate non-affiliate market value reaches or exceeds $75M.

10-03-2026

Cadre Holdings reported full year 2025 net sales of $610.3M, up 7.6% YoY from $567.6M, driven by acquisitions and duty gear demand, achieving record adjusted EBITDA of $111.7M (up 6.6% YoY) and gross margin expansion of 140 bps to 42.5%, with net income rising to $44.1M. However, Q4 net sales declined 5.0% YoY to $167.2M from $176.0M due to prior-year cyber incident shipments, adjusted EBITDA fell 10.7% to $34.4M, and declines occurred in EOD products and existing nuclear safety products. Guidance for 2026 projects net sales of $736-758M (22% YoY growth at midpoint) and adjusted EBITDA of $136-141M (24% growth), bolstered by recent TYR Tactical acquisition and a 5.3% dividend increase.

• ·Product segment gross margin: 43.5% FY2025 (up from 42.2% FY2024) but 44.2% Q4 2025 (down from 45.4% Q4 2024)
• ·Distribution segment gross margin: 22.0% FY2025 (down from 22.5% FY2024) and 21.9% Q4 2025 (up from 21.8% Q4 2024)
• ·Capital expenditures: $7.0M FY2025 (up from $5.8M FY2024)
• ·Net debt increased to $184.4M as of Dec 31, 2025 from $98.3M as of Dec 31, 2024
• ·Shares outstanding: 42,160,656 as of Dec 31, 2025

10-03-2026

On December 10, 2025, Scorpius Holdings, Inc. lost ownership of substantially all non-cash assets related to its CDMO and R&D activities via a foreclosure sale by 3i, LP, generating $15.2M net proceeds to partially settle $30.2M secured debt, resulting in pro forma total assets dropping to $0.87M from $20.8M as of September 30, 2025. Pro forma net losses attributable to Scorpius improved significantly (9 months ended Sep 30, 2025: $1.5M vs. reported $15.8M; FY2024: $8.5M vs. $32.8M; FY2023: $21.8M vs. $45.2M), reflecting removal of discontinued operations, but stockholders' deficit worsened to $19.8M and remaining liabilities stood at $25.3M. All CDMO employees were terminated, with most joining buyer Velocity Bioworks, Inc., a subsidiary of Tivic Health Systems, Inc.

• ·Pro forma revenue eliminated to $0 for 9 months ended Sep 30, 2025 (previously $0.67M).
• ·Pro forma operating expenses reduced to $7.3M for 9 months ended Sep 30, 2025 (previously $25.0M).
• ·Derecognition of $9.6M finance lease ROU assets and $6.1M liabilities; $0.6M operating lease ROU assets and $0.7M liabilities.

10-03-2026

Capital City Bank Group, Inc.'s DEF 14A proxy statement outlines robust cybersecurity governance, with the CISO (over 15 years experience) managing the program and reporting quarterly to the Enterprise Risk Oversight Committee and annually to the Board. The Board, which met 9 times in 2025 with 97.6% attendance, maintains a majority-independent structure (10 independent directors listed), led by Chairman/CEO William G. Smith, Jr. and Lead Independent Director Stanley W. Connally, Jr.; independent directors held 5 executive sessions. In 2025, an external firm evaluated board performance, and all directors attended the annual meeting.

• ·Directors may serve on no more than 3 other public company boards (CEO limited to 2).
• ·Majority of Board determined independent under Nasdaq rules, considering ordinary course banking services and architectural fees to BKJ.
• ·Corporate Governance and Nominating Committee engaged Bank Director for 2025 board evaluation via anonymous questionnaires.
• ·All directors attended the 2025 Annual Meeting.
• ·Resignation tender required in uncontested elections if nominee fails majority vote; Board decides within 90 days.

10-03-2026

Elevance Health, Inc. reaffirmed its FY2026 adjusted shareholders’ earnings guidance at least $25.50 per diluted share and benefit expense ratio of 90.2% plus or minus 50 basis points, incorporating the potential impact of CMS sanctions. These sanctions, notified on February 27, 2026, would suspend Medicare Advantage-Prescription Drug plan enrollments and certain communications effective March 31, 2026, unless resolved. The guidance reflects confidence despite this regulatory risk.

• ·CMS notified Company of sanctions intent on February 27, 2026, as reported in prior 8-K filed March 2, 2026
• ·Sanctions effective March 31, 2026, unless issues addressed
• ·No GAAP reconciliation provided for adjusted EPS guidance due to uncertain financial payments related to sanctions

10-03-2026

UWM Holdings Corporation filed a Form 8-K on March 10, 2026, reporting a press release issued on March 9, 2026, under Item 7.01 Regulation FD Disclosure, with the press release furnished as Exhibit 99.1. The filing was signed by Rami Hasani, Executive Vice President and Chief Financial Officer. No specific financial or operational details from the press release are included in the filing body.

• ·Securities registered: Class A Common Stock (UWMC) on New York Stock Exchange
• ·Company address: 585 South Boulevard E., Pontiac, Michigan 48341
• ·Registrant’s telephone: (800) 981-8898

10-03-2026

Barnes & Noble Education reported fiscal Q3 2026 revenue of $515.1 million, up 11.3% YoY from $462.8 million, driven by strong 32.1% growth in BNC First Day revenues to $293.6 million and 7.2% higher gross comparable store sales; however, net income declined to $6.7 million from $17.9 million due to the absence of prior one-time gains, and Adjusted EBITDA dipped slightly to $23.6 million from $24.8 million amid gross margin timing issues. For the first nine months of FY2026, revenue increased 9.0% to $1,447.7 million, net income swung to $13.4 million from a $42.8 million loss, and Adjusted EBITDA rose 5.5% to $61.9 million. The company announced a $0.08 per share quarterly dividend starting Q1 FY2027 and a virtual Investor Day on June 25, 2026.

• ·Total debt increased to $138.4 million as of January 31, 2026 from $122.5 million as of November 1, 2025; net debt $128.3 million after $10.1 million cash.
• ·Net working capital $245.9 million as of January 31, 2026 vs. $186.2 million as of May 3, 2025.
• ·FY2026 outlook: Adjusted EBITDA $65-75 million; ~$18 million capital expenditures; FY2027 Adjusted EBITDA growth target 15-20% or more.
• ·Q3 Adjusted Free Cash Flow $(38.3) million vs. $(49.4) million prior year; first nine months $(54.3) million vs. $(160.3) million.
• ·Dividend yield approx. 3.5% at $8.80 per share.

10-03-2026

Alexander & Baldwin, Inc. held a special shareholder meeting on March 9, 2026, approving all three proposals related to the Merger Agreement dated December 8, 2025, with Tropic Purchaser LLC and Tropic Merger Sub LLC. The Merger Agreement Proposal passed overwhelmingly with 57,355,918 votes for, 424,197 against, and 113,557 abstentions on a quorum of 57,893,672 shares (79.50% of 72,820,075 outstanding shares). The merger is expected to close on or about March 12, 2026, subject to conditions.

• ·Record date for Special Meeting: January 15, 2026.
• ·Definitive Proxy Statement first mailed to shareholders on or about January 23, 2026.
• ·No broker non-votes occurred as proposals were non-routine.
• ·No other business came before the Special Meeting.

10-03-2026

York Space Systems Inc. (YSS) entered into a Merger Agreement on March 6, 2026, to acquire all issued and outstanding equity interests of Orbion Space Technology, Inc. in exchange for cash and 2,812,141 shares of YSS common stock. The shares, subject to transfer restrictions, were issued under a Section 4(a)(2) exemption from Securities Act registration requirements.

• ·Merger involves Orbion sellers’ representative.
• ·Filing signed March 9, 2026; reported under Item 3.02 Unregistered Sales of Equity Securities.

10-03-2026

dMY Squared Technology Group, Inc., Horizon Quantum Holdings Ltd., and Horizon Quantum Computing Pte. Ltd. amended PIPE Subscription Agreements with certain investors, introducing a 'Reduction Right' allowing them to satisfy part of their $111.9M PIPE commitment using dMY Class A common shares owned or purchased in the open market, subject to specific voting and non-redemption conditions, ahead of the Business Combination special meeting. The amendment to the IonQ side letter removes the prior condition requiring a commercial agreement for quantum hardware purchase, facilitating IonQ's participation. No financial declines or flat metrics are reported, but the filing highlights ongoing risks to deal completion.

• ·PIPE Subscription Agreements originally dated December 4, 2025 and March 6, 2026
• ·Amendment to PIPE Agreements and IonQ Side Letter executed March 9, 2026
• ·Reduction Right election deadline: one Business Day prior to dMY stockholder redemption deadline
• ·Business Combination Agreement dated September 9, 2025
• ·Registration Statement effective February 17, 2026; definitive Proxy Statement mailed same day

10-03-2026

Creative Media & Community Trust Corp (CMCT) reported total revenues of $116.7M for the year ended December 31, 2025, down 6.3% YoY from $124.5M, with declines in office (-7.6%), multifamily (-19.1%), and lending (-16.7%) segments offsetting hotel growth of 4.9%. Net loss widened 53.7% to $39.6M from $25.8M amid higher expenses (+2.7%) and a $3.7M real estate impairment, though FFO attributable to common stockholders improved to -$31.5M from -$46.3M and total assets stood at $859.2M, down from $889.6M.

• ·Sheraton Grand Hotel (Sacramento, CA) had 72.5% occupancy and $152.70 RevPAR.
• ·Investments in real estate, net: $698.1M (2025) vs. $709.2M (2024).
• ·Loans receivable, net: $0 (2025) vs. $56.2M (2024).
• ·Net loss attributable to common stockholders per share: $(67.08) basic and diluted (2025) vs. $(431.43) (2024).
• ·Weighted average common shares outstanding: 919K basic and diluted (2025) vs. 170K (2024).

10-03-2026

M&T Bank Corporation issued a DEFA14A notice for its 2026 Annual Meeting of Shareholders, to be held virtually on April 21, 2026, at 11:00 a.m. Eastern Time. Shareholders will vote on electing 12 directors for one-year terms, advisory approval of 2025 named executive officer compensation, amendment and restatement of the 2019 Equity Incentive Compensation Plan, and ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026. Proxy materials are available online at envisionreports.com/MTB, with requests for paper copies needed at least 10 days prior to the meeting.

• ·Virtual meeting URL: meetnow.global/MVLYTF9
• ·Proxy request methods: Internet at envisionreports.com/MTB, phone 1-866-641-4276, or email to investorvote@computershare.com
• ·Board recommends vote FOR all director nominees, Proposal 2, Proposal 3, and Proposal 4

10-03-2026

Kohl’s reported Q4 FY2025 net sales of $5.0B, down 3.9% YoY with comparable sales down 2.8%, while full-year net sales fell 4.0% to $14.8B with comparable sales down 3.1%; however, operating income rose to $212M in Q4 (from $126M) and $624M full-year (from $433M), driven by gross margin expansion and SG&A reductions. Adjusted diluted EPS improved to $1.07 in Q4 and $1.62 full-year, with strong cash flow from operations at $750M in Q4 and $1.4B full-year. The company introduced FY2026 guidance for net sales down 2% to flat and share repurchases via dividend of $0.125/share.

• ·Borrowings under revolving credit facility reduced to $0 from $290M YoY.
• ·FY2026 guidance: Adjusted operating margin 2.8% to 3.4%; Adjusted diluted EPS $1.00 to $1.60; Capex $350M to $400M.
• ·Quarterly dividend $0.125 per share, payable April 1, 2026 to shareholders of record March 18, 2026.
• ·Cash and equivalents increased to $674M from $134M.

10-03-2026

Soluna Holdings, Inc. filed an 8-K on March 10, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, announcing a press release with previously unreported corporate and operational information regularly published on its website. The press release is furnished as Exhibit 99.1 and not deemed 'filed' under the Exchange Act. No specific financial or operational metrics are detailed in the filing body.

• ·Filing incorporates press release dated March 10, 2026, as Exhibit 99.1.
• ·Registrant incorporated in Nevada, EIN 14-1462255, principal offices in Albany, New York.

10-03-2026

Harvard Bioscience, Inc. entered into an amended employment agreement with CEO John Duke effective March 6, 2026, providing a $515,000 annual base salary, a $100,000 cash bonus upon successful credit facility refinancing, up to 80% incentive compensation, and a target 75,000 RSUs for 2026 post 1:10 reverse stock split. The Board appointed Mark Frost as permanent CFO and Treasurer, effective the same date, with a $375,000 base salary, up to 60% incentive compensation, and target 30,000 RSUs for 2026 post reverse stock split. Both agreements supersede prior ones and include severance benefits for certain termination events.

• ·Duke agreement term extends to July 16, 2027, with automatic two-year renewals.
• ·Frost agreement term extends to April 10, 2027, with automatic two-year renewals.
• ·Duke prior agreement dated July 16, 2025; Frost prior agreement dated April 10, 2025.
• ·Reverse stock split (1:10) effective March 13, 2026.
• ·Frost served as Interim Financial Officer from April 10, 2025, to March 6, 2026.

10-03-2026

vTv Therapeutics Inc. (VTVT) announced on March 10, 2026, the posting of an updated investor slide presentation on its website, to be used in meetings with investors, analysts, and other parties. The presentation is attached as Exhibit 99.1 and may be amended in the future. No specific financial or operational updates are detailed in the filing.

10-03-2026

U.S. Bancorp issued Definitive Additional Proxy Materials (DEFA14A) for its 2026 Annual Meeting of Shareholders on April 21, 2026, at 11:00 AM Central Time, held virtually at www.virtualshareholdermeeting.com/USB2026. Key proposals include the election of 12 directors, an advisory vote to approve executive compensation, and ratification of Ernst & Young LLP as independent auditors for fiscal 2026, with the Board recommending FOR on all items. Shareholders must vote by April 20, 2026, 11:59 PM ET (or April 16 for plan-held shares), and can request paper copies by April 7, 2026.

• ·Meeting accessible virtually at www.virtualshareholdermeeting.com/USB2026
• ·Proxy materials available at www.ProxyVote.com or by calling 1-800-579-1639
• ·Investor Relations address: 800 Nicollet Mall, BC-MN-H23K, Minneapolis, MN 55402-7014

10-03-2026

Valhi, Inc. reported a Q4 2025 net loss of $53.2M ($1.86/share) versus net income of $22.8M ($0.80/share) in Q4 2024, and a FY 2025 net loss of $57.6M ($2.02/share) versus $108.0M ($3.79/share) in FY 2024, primarily driven by Chemicals Segment operating losses of $60.1M in Q4 and $24.5M for FY amid lower TiO2 prices (down 8% Q4 YoY, 4% FY YoY) and reduced production capacity (77% FY vs 96% prior). Component Products Segment showed gains with FY sales up 9% to $158.3M and operating income up 33% to $22.6M, while Real Estate sales doubled Q4 to $38.5M but fell 17% FY to $59.3M. Chemicals sales declined 1% both Q4 ($418.3M) and FY ($1.9B).

• ·Chemicals Q4 production: 55% capacity vs 97% prior; Q1-Q3 2025: 93%, 81%, 80%.
• ·Currency (euro) boosted Chemicals Q4 sales by $13M and FY by $24M; reduced operating loss by $3M Q4 and $8M FY.
• ·Real Estate Q4 included $6.3M immediate revenue from parcels with no development obligations.
• ·Corporate interest expense up $1.9M Q4 and $7.2M FY due to higher debt and rates.

10-03-2026

On March 10, 2026, Patriot National Bancorp, Inc. posted a presentation on its Investor Relations website containing certain Q4 2025 financial information for its wholly owned subsidiary, Patriot Bank, National Association. The disclosure is furnished under Regulation FD (Item 7.01) and includes Exhibit 99.1, but is not deemed 'filed' for purposes of Section 18 of the Exchange Act. No specific financial metrics, period-over-period changes, or performance details were disclosed in the filing text.

• ·Filing applies to Common Stock, par value $0.01 per share (PNBK) on NASDAQ Global Market
• ·Information furnished as Exhibit 99.1 (Presentation)
• ·Not an emerging growth company

10-03-2026

Bank of Marin Bancorp (Nasdaq: BMRC), parent of Bank of Marin, announced that President and CEO Tim Myers and EVP and CFO David Bonaccorso will participate in the Stephens Virtual West Coast Bank Trip on March 11, 2026. A copy of the presentation will be available on the company's website under Investor Relations on March 10, 2026, furnished as Exhibit 99.1.

• ·Presentation available at http://www.bankofmarin.com under “Investor Relations/News & Market Data/Presentations”

10-03-2026

Reliance Global Group, Inc. reported a net loss of $7.0M for the year ended December 31, 2025, an improvement of 23% YoY from $9.1M in 2024, primarily due to a $3.2M gain on the sale of businesses including Fortman Insurance Services (FIS), Employee Benefits Solutions (EBS), and U.S. Benefits Alliance (USBA). However, commission income declined 12% YoY to $12.4M amid these portfolio realignments, loss from operations worsened 17% to $9.0M, total operating expenses were nearly flat at a 1% decrease to $21.4M, and AEBITDA deteriorated sharply 397% to $(1.6M). Cash flows showed a net increase of $0.9M, reversing a $0.9M decrease in 2024, supported by $5.3M from investing activities.

• ·Salaries and wages increased 43% YoY to $10.3M, driven by non-cash share-based compensation.
• ·Equity-based compensation totaled $5.7M in 2025, up significantly from $0.9M in 2024.
• ·Net cash used in operating activities increased to $3.1M from $2.5M YoY.
• ·Asset sales contributed to $5.3M net cash from investing activities in 2025.

10-03-2026

Mayville Engineering Company, Inc. (MEC) filed a definitive proxy statement for its 2026 Annual Meeting of Shareholders, to be held virtually on April 21, 2026, at 2:00 P.M. Central Time. Agenda items include electing three directors to serve until the 2029 annual meeting, ratifying Deloitte & Touche LLP as the independent auditor for 2026, and an advisory 'say-on-pay' vote on named executive officer compensation. As of the record date of February 20, 2026, 20,318,370 shares of common stock were outstanding and entitled to vote.

• ·Record date for voting eligibility: February 20, 2026
• ·ESOP and 401(k) Plan voting instructions deadline: April 16, 2026
• ·Virtual meeting platform: www.virtualshareholdermeeting.com/MEC2026 with online check-in at 1:45 P.M. Central Time
• ·Proxy voting options: www.proxyvote.com or telephone 1-800-690-6903

10-03-2026

Sirius XM Radio LLC, a subsidiary of Sirius XM Holdings Inc., settled its cash tender offer on March 5, 2026, purchasing $498.9 million (49.89%) of its outstanding 3.125% Senior Notes due 2026, leaving $501.1 million outstanding. On March 10, 2026, SiriusXM deposited sufficient funds with the trustee to satisfy and discharge the remaining notes and the related indenture, funded by proceeds from its newly issued 5.875% Senior Notes due 2032 issued on March 4, 2026. This refinancing extends debt maturity from 2026 to 2032 but increases the coupon rate from 3.125% to 5.875%.

• ·Tender offer funded by net proceeds from 5.875% Senior Notes due 2032 issuance on March 4, 2026.
• ·Satisfaction and Discharge completed under the Indenture dated August 16, 2021.

10-03-2026

AeroVironment reported Q3 FY26 revenue of $408M, up 143% YoY from $167.6M, driven by the BlueHalo acquisition contributing $176.5M and record funded backlog of $1.1B with 9-month bookings of $2.1B and book-to-bill of 1.6. However, gross margin declined to 24% of revenue from 38% due to service mix and $12.7M in non-cash acquisition expenses, while a $151.3M goodwill impairment in the Space unit from a stop-work order on the BADGER/SCAR program led to a net loss of $156.6M versus $1.8M last year. FY26 guidance projects revenue of $1.85-1.95B but net loss of $(218)-(201)M.

• ·AxS segment Q3 revenue $278.7M; SCDE segment $129.3M.
• ·Non-GAAP EPS Q3 FY26 $0.64 vs $0.30 prior year.
• ·FY26 guidance: non-GAAP adjusted EBITDA $265-285M; non-GAAP EPS $2.75-3.10; net loss per share $(4.44)-(4.10).
• ·Stop-work order received January 2026 on BADGER for Space Force SCAR program.

10-03-2026

Artiva Biotherapeutics reported a widened net loss of $83.9M for the year ended December 31, 2025, up 28% from $65.4M in 2024, primarily due to sharply higher R&D expenses of $69.5M (up 38% YoY) and total operating expenses rising 33% YoY to $89.8M, with no license revenue versus $0.3M in 2024. Cash and cash equivalents declined to $26.7M from $40.2M, and total assets fell 38% to $130.9M, reflecting increased cash burn from operations at $76.8M (up 39% YoY). While interest income improved slightly to $6.0M (up 11% YoY) and investing activities provided $63.4M in net cash, stockholders' equity dropped to $110.0M from $186.6M.

• ·Common shares outstanding increased slightly to 24.6M from 24.3M.
• ·Stock-based compensation expense slightly declined to $6.8M from $7.0M.
• ·Net cash provided by investing activities swung to $63.4M from -$120.5M due to investment maturities.

10-03-2026

Evolv Technologies Holdings, Inc. reported FY2025 total revenue of $145.9M, up 40% YoY from $103.9M, with product revenue surging 235% to $21.6M and subscription revenue growing 29% to $83.8M. However, net loss narrowed to $33.1M from $54.0M (39% improvement), but product revenue gross margin remained negative at -12% (improved from -66%), subscription margin dipped 1pp to 56%, and service margin declined 7pp to 71%. Adjusted EBITDA swung to positive $11.1M from -$21.0M, while operating cash flow turned positive at $18.7M versus -$30.9M prior year.

• ·R&D expenses decreased 12% YoY to $20.6M.
• ·Total operating expenses fell 13% YoY to $123.8M.
• ·Net cash used in investing activities increased to $41.8M from $1.4M.
• ·Gross profit margin for license fee and other revenue declined 4pp to 89%.

10-03-2026

Invesco Mortgage Capital Inc. (NYSE: IVR) appointed Stephanie J. Larosiliere, a veteran fixed income expert with over two decades of experience and current Head of Business Strategy and Development for Invesco Ltd. Fixed Income in North America & APAC, to its Board of Directors as an executive director, effective March 6, 2026. The appointment is intended to strengthen stockholder engagement, alignment, and institutional investor relations. Don Liu, Chair of the Board, emphasized her expertise in fixed income markets and ability to identify emerging trends.

• ·Company is a real estate investment trust externally managed by Invesco Advisers, Inc.
• ·Investor Relations Contact: Gregory Seals, 404-439-3323
• ·Website: www.invescomortgagecapital.com

10-03-2026

Aviat Networks, Inc. filed an 8-K on March 10, 2026, under Items 8.01 and 9.01, to submit an updated Consent of Independent Registered Public Accounting Firm from Deloitte & Touche LLP as Exhibit 23. This consent, dated March 10, 2026, references the Company's Registration Statement No. 333-279014 on Form S-3, which was not included in the original Form 10-K filed on September 10, 2025, for the fiscal year ended June 27, 2025, due to S-3 ineligibility at the time. The filing confirms no changes to previously reported financial results or disclosures.

• ·Original Form 10-K filed September 10, 2025, for fiscal year ended June 27, 2025
• ·Original consent dated September 10, 2025, filed as Exhibit 23 to 10-K

10-03-2026

Equity Bancshares Inc reported net income of $22.7M for 2025, down 64% YoY from $62.6M in 2024, primarily due to a $53.2M net loss on securities transactions, higher merger expenses of $8.1M, and elevated other non-interest expenses at $165.3M (up 18%). However, net interest income grew 21% YoY to $226.1M supported by 20% loan growth to $4.20B gross and total assets expanding 19% to $6.37B, with NIM improving to 4.33% from 3.98%. ROAA declined sharply to 0.40% from 1.23%, while capital ratios remained solid with Total Risk Based Capital at 16.31%.

• ·Shares outstanding: 20,992,139 Class A as of February 27, 2026.
• ·Equity compensation plans: Weighted average exercise price $30.07 for 458,133 options.
• ·Core diluted EPS flat at $4.39 in 2025 vs $4.43 in 2024.
• ·Tier 1 Leverage Ratio declined to 10.64% from 11.67%.
• ·Book value per share $38.64 at Dec 31, 2025 (up from $34.04).

10-03-2026

IBM's 2026 Definitive Proxy Statement (DEF 14A) filed on March 10, 2026, invites stockholders to the virtual Annual Meeting on April 28, 2026, to vote on electing 13 director nominees, ratifying PricewaterhouseCoopers LLP as independent auditors, an advisory vote on executive compensation, approval of the 2026 long-term performance plan, and four stockholder proposals if properly presented. The company reports qualitative 2025 growth, innovation, and strong stockholder results driven by AI and hybrid cloud strategies, with the addition of Ramon Laguarta to the Board enhancing expertise in transformation and global strategy. The Board highlights robust governance, independent leadership, risk oversight, and ongoing stockholder engagement with no noted declines or challenges.

• ·Annual Meeting: Tuesday, April 28, 2026 at 1:00 p.m. Eastern Time, virtual at www.virtualshareholdermeeting.com/IBM2026
• ·Fiscal year end: December 31
• ·13 director nominees for one-year terms
• ·Stockholder proposals: (1) change to outside director stock ownership guidelines, (2) right to act by written consent, (3) report on AI bias, (4) report on discrimination in charitable support

10-03-2026

Kodiak AI announced Q4 and FY 2025 results, with revenue of $1.1M reflecting 37% QoQ growth, deployments expanding to 20 fully driverless trucks (100% QoQ increase from 10), and cumulative paid driverless operations reaching over 10,700 hours (106% QoQ increase). However, the company reported net cash used in operating activities of $24.2M and negative free cash flow of $34M, though better than guided negative $36-38M range. Balance sheet strengthened to $120.7M in cash, cash equivalents, and marketable securities after a $30M debt refinancing.

• ·Deployed 10 additional trucks to Atlas Energy Solutions.
• ·Introduced capability to pull three trailers with one tractor.
• ·Announced collaboration with Bosch for next-generation platform.
• ·Launched Dallas-Fort Worth to El Paso route and new Dallas-Houston pilot.
• ·Upcoming: JP Morgan Industrials Conference on March 17, 2026.

10-03-2026

Evergy, Inc. filed an 8-K on March 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified metrics, positive or negative developments mentioned.

10-03-2026

Invesco Ltd. filed an 8-K on March 10, 2026, under Items 7.01 and 9.01, announcing preliminary assets under management for the month ended February 28, 2026, via a press release attached as Exhibit 99.1. The filing incorporates the press release by reference under Regulation FD.

• ·Date of earliest event reported: March 10, 2026
• ·AUM period: month ended February 28, 2026
• ·Securities registered: Common stock, $.20 par value (IVZ) on New York Stock Exchange

10-03-2026

Shoulder Innovations, Inc. reported net revenue growth of 49.6% YoY to $47.3M for the year ended December 31, 2025, from $31.6M in 2024, with gross profit increasing 48.7% to $36.2M. However, operating expenses rose 60.3% to $62.5M, driven by SG&A up 58.7% and R&D up 72.2%, resulting in an operating loss widening 79.5% to $26.3M and net loss expanding 158.4% to $40.4M. The company completed an IPO, boosting total assets to $170M and converting to positive stockholders' equity of $140.8M, though cash used in operating activities more than doubled to $28.6M.

• ·Adjusted EBITDA loss widened to $(36.1M) from $(11.4M).
• ·Cash increased to $26.9M from $6.1M, driven by $145.0M financing inflows including IPO net proceeds of $64.2M.
• ·Inventories grew to $21.6M from $14.0M; accounts receivable to $8.3M from $5.1M.
• ·Long-term debt steady at ~$14.9M.

10-03-2026

Advance Auto Parts, Inc. (NYSE: AAP) appointed Cynthia Jamison as an independent director to its Board of Directors on March 10, 2026, citing her extensive experience in retail, consumer products, and executive leadership. Jamison, former CFO of AquaSpy, Inc. and Partner at Tatum, LLC, currently chairs the board of Darden Restaurants, Inc. and serves on boards including International Flavors & Fragrances, Inc. The company operates 4,305 stores and serves 809 independently owned Carquest branded stores as of January 3, 2026.

• ·Jamison served as CFO of AquaSpy, Inc. (2010-2013), Partner at Tatum, LLC (1999-2009) leading CFO Practice for over 300 partners, and held C-suite roles at Chart House Enterprises, Allied Domecq Retailing USA, Kraft General Foods, and Arthur Andersen.
• ·Jamison previously chaired boards of Tractor Supply Company and Big Lots, Inc., and served on boards of Office Depot, Inc., B&G Foods, Cellu Tissue Holdings, Inc., and Horizon Organic Holdings Corp.

10-03-2026

Liberty Global Ltd. filed a Form 8-K on March 10, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, furnishing a press release dated March 10, 2026, as Exhibit 99.1. The filing contains no specific financial or operational details from the press release, which is not deemed 'filed' under Section 18 of the Exchange Act.

10-03-2026

Natural Grocers by Vitamin Cottage, Inc. (NGVC) held its 2026 annual meeting of stockholders virtually on March 4, 2026, with 21,267,524 shares represented, constituting 92.33% of outstanding shares. Stockholders elected Zephyr Isely, David Rooney, and Sandra Buffa as Class II directors for a three-year term, with For votes ranging from 16.0M to 17.5M shares and broker non-votes of 1.7M. Proposal No. 2 to ratify KPMG LLP as independent auditor for FY ending September 30, 2026, passed overwhelmingly with 21.1M For votes.

• ·Director votes - Zephyr Isely: For 16,026,727; Withheld 3,521,239
• ·Director votes - David Rooney: For 16,760,662; Withheld 2,787,304
• ·Director votes - Sandra Buffa: For 17,466,551; Withheld 2,081,415
• ·KPMG ratification: Against 131,811; Abstain 63,919

10-03-2026

The U.S. Bankruptcy Court for the Southern District of Texas confirmed the Amended Joint Prepackaged Plan of Reorganization for Nine Energy Service, Inc. and its debtor affiliates on March 4, 2026, following Chapter 11 petitions filed on February 1, 2026, and a Restructuring Support Agreement (RSA) executed the same day with over 70% of Senior Secured Notes Claims holders and 100% of Prepetition ABL Claims holders. The rapid prepackaged process, completed in just over a month with no unresolved objections, reflects strong creditor support but underscores the company's debt distress necessitating bankruptcy reorganization. No financial metrics were disclosed in the order.

• ·Case No. 26-90295 (CML) in the Southern District of Texas, Houston Division
• ·Petition Date: February 1, 2026
• ·Combined Hearing Date: March 4, 2026
• ·Principal place of business: 2001 Kirby Drive, Suite 200, Houston, TX 77019
• ·Claims agent website: https://dm.epiq11.com/NineEnergy

10-03-2026

Vanda Pharmaceuticals Inc. CEO Mihael Polymeropoulos disclosed on Fox Business that NEREUS™, recently FDA-approved for preventing motion-induced vomiting, will launch in the next couple of months with discussions on pricing and commercial strategy. The company is developing NEREUSRX™, a direct-to-consumer channel for accessing NEREUS™. No financial metrics or performance comparisons were provided.

• ·NEREUS™ FDA-approved for prevention of vomiting induced by motion
• ·Full interview available at: https://www.foxbusiness.com/video/6390680373112

10-03-2026

CVG reported Q4 2025 revenue of $154.8 million, down 5.2% YoY from $163.3 million due to softer North American demand, and full-year 2025 revenue of $649.0 million, down 10.3% YoY from $723.4 million. Despite revenue declines, operating losses improved (Q4 to $1.8 million from $5.3 million), adjusted EBITDA rose 155.6% to $2.3 million in Q4, free cash flow reached $34.0 million for the full year (up $21.5 million), and debt decreased $29.1 million; however, Trim Systems and Components revenue fell 22.5% YoY while Global Electrical Systems grew 12.7%. The company named as Zoox Robotaxi low voltage wire harness strategic supplier and provided 2026 outlook of $660-700 million in net sales and $24-30 million adjusted EBITDA.

• ·Q4 2025 adjusted operating loss of $0.9 million, improved from $4.3 million in Q4 2024.
• ·Full year 2025 SG&A expenses declined $4.8 million YoY.
• ·As of Dec 31, 2025: $16.8 million U.S. revolver borrowings, $1.4 million China facility borrowings, $101.8 million availability.
• ·2026 outlook: Positive free cash flow; Construction end market low-single digit growth.

10-03-2026

IF Bancorp, Inc. entered into a Contingent Payment Agreement with ServBanc Holdco, Inc. on March 9, 2026, allowing Iroquois Federal Savings and Loan Association to renew a $13.995M loan participation for up to 180 days after establishing a $7M specific reserve, with ServBanc funding a $5.005M contingent payment potentially distributable to IF Bancorp shareholders if the loan is sufficiently repaid. The merger, agreed on October 29, 2025, is expected to close on March 12, 2026, with cash consideration of $26.40 per share plus up to $1.51 per share from the contingent fund net of expenses; however, there is no guarantee of any contingent payment, as undistributed funds revert to ServBanc.

• ·Merger Agreement dated October 29, 2025
• ·Renewal Period: 120 days with possible additional 60-day extension
• ·Contingent Payment Fund reflects tax-effected impact of the $7M reserve on tangible common equity
• ·Keefe Bruyette and Woods, Inc. as financial advisor